Targeting toll-like receptors 4 intracellular domain to prevent ischemic liver disease: an innovative approach or just a futuristic dream?

Crit Care Med. 2014 Feb;42(2):487-8. doi: 10.1097/CCM.0000000000000005.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Liver / blood supply*
  • Male
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Reperfusion Injury / prevention & control*
  • Toll-Like Receptor 4 / antagonists & inhibitors*
  • Warm Ischemia*

Substances

  • Receptors, Interleukin-1
  • Toll-Like Receptor 4